Implementing single-dose HPV vaccination in Canada.
- 1Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, Canada.
- 2Department of Anthropology, Laval University, Québec City, Canada.
- 3Department of Psychiatry and Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Abstract
The World Health Organization and the National Advisory Committee on Immunization now recommend a single-dose HPV vaccine schedule for most immunocompetent adolescents. As Canadian jurisdictions transition to a single-dose schedule, we apply a social and behavioral science lens and draw on lessons from previous vaccine schedule changes and international experience to identify potential challenges and opportunities associated with this transition. Key implementation considerations include maintaining public confidence through transparent communication about the rationale for the schedule change, ensuring healthcare providers, immunizers, and parents are adequately prepared to support the transition, and promoting equitable access through robust catch-up programs and targeted outreach initiatives. Attention to these factors will be critical to supporting successful implementation of single-dose HPV vaccination programs in Canada.
Related
- Perspectives on implementing nerve and tendon transfer surgery in spinal cord injury rehabilitation in the USA and Canada: a qualitative study.
- Persistent Varicella Transmission in a High-Coverage Single-Dose Vaccination Program: Costa Rica, 2015-2024.
- Changes in Post-Transplant Vaccine Coverage After Implementing Structured Vaccine Reviews in Pediatric Solid Organ Transplant Recipients in British Columbia, Canada: A Canadian Immunization Research Network Study.
- High-dose vitamin D3 supplementation in the prevention of viral-induced asthma in high-morbidity preschoolers (DIVA): a randomised controlled trial in Canada
- Short‐Term Adverse Events Following Recombinant Zoster Vaccination in Older Adults in Australia: A Survey Study Comparing Dose 1 and Dose 2 and Influence of Dose Interval
BibTeX
@article{leggatt2026implementing,
title = {{Implementing single-dose HPV vaccination in Canada.}},
author = {Madison Leggatt and Nivatha Moothathamby and Ève Dubé and Gilla K Shapiro},
journal = {Human vaccines \& immunotherapeutics},
year = {2026},
month = oct,
doi = {10.1080/21645515.2026.2749306},
url = {https://europepmc.org/article/MED/42899377},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Implementing single-dose HPV vaccination in Canada.
AU - Madison Leggatt
AU - Nivatha Moothathamby
AU - Ève Dubé
AU - Gilla K Shapiro
PY - 2026
DA - 2026/10/20
JO - Human vaccines & immunotherapeutics
DO - 10.1080/21645515.2026.2749306
UR - https://europepmc.org/article/MED/42899377
AB - The World Health Organization and the National Advisory Committee on Immunization now recommend a single-dose HPV vaccine schedule for most immunocompetent adolescents. As Canadian jurisdictions transition to a single-dose schedule, we apply a social and behavioral science lens and draw on lessons from previous vaccine schedule changes and international experience to identify potential challenges and opportunities associated with this transition. Key implementation considerations include maintaining public confidence through transparent communication about the rationale for the schedule change, ensuring healthcare providers, immunizers, and parents are adequately prepared to support the transition, and promoting equitable access through robust catch-up programs and targeted outreach initiatives. Attention to these factors will be critical to supporting successful implementation of single-dose HPV vaccination programs in Canada.
SN - 2164-5515
SN - 2164-554X
ER -